Otsuka Pharmaceutical Co. Ltd. on March 3 announced that it will acquire U.S.-based bioventure Neurovance Inc., which is developing a treatment…...
Please subscribe to read the full story.
Alzheimer's disease
Toyama Chemical Works on Drug Development for Facilitating Post-Stroke Rehabilitation
Fujifilm Group company Toyama Chemical Co. Ltd. is setting out to develop a drug to facilitate post-stroke rehabilitation, working together…...
Please subscribe to read the full story.
